Improving sensitivity through data augmentation with synthetic lymph node metastases for AI-based analysis of PSMA PET-CT images
Artikel i vetenskaplig tidskrift, 2024

Background: We developed a fully automated artificial intelligence (AI)AI-based-based method for detecting suspected lymph node metastases in prostate-specific membrane antigen (PSMA)(PSMA) positron emission tomography-computed tomography (PET-CT)(PET-CT) images of prostate cancer patients by using data augmentation that adds synthetic lymph node metastases to the images to expand the training set. Methods: Synthetic data were derived from original training images to which new synthetic lymph node metastases were added. Thus, the original training set from a previous study (n = 420) was expanded by one synthetic image for every original image (n = 840), which was used to train an AI model. The performance of the AI model was compared to that of nuclear medicine physicians and a previously developed AI model. The human readers were alternately used as a reference and compared to either another reading or AI model. Results: The new AI model had an average sensitivity of 84% for detecting lymph node metastases compared with 78% for human readings. Our previously developed AI method without synthetic data had an average sensitivity of 79%. The number of false positive lesions were slightly higher for the new AI model (average 3.3 instances per patient) compared to human readings and the previous AI model (average 2.8 instances per patient), while the number of false negative lesions was lower. Conclusions: Creating synthetic lymph node metastases, as a form of data augmentation, on [18F]PSMA-1007F]PSMA-1007 PETPET-CT-CT images improved the sensitivity of an AI model for detecting suspected lymph node metastases. However, the number of false positive lesions increased somewhat.

PSMA

PET-CT

artificial intelligence

prostate cancer

machine learning

synthetic data

Författare

E. Tragardh

Lunds universitet

Skånes universitetssjukhus (SUS)

Johannes Ulén

Eigenvision AB

Olof Enqvist

Eigenvision AB

Chalmers, Elektroteknik, Signalbehandling och medicinsk teknik

L. Edenbrandt

Göteborgs universitet

Måns Larsson

Eigenvision AB

Clinical Physiology and Functional Imaging

1475-0961 (ISSN) 1475097x (eISSN)

Vol. In Press

Ämneskategorier

Radiologi och bildbehandling

Cancer och onkologi

DOI

10.1111/cpf.12879

PubMed

38563413

Mer information

Senast uppdaterat

2024-04-24